Donald Hooker
Stock Analyst at Keybanc
(2.50)
# 2,297
Out of 5,114 analysts
81
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $7.23 | +1,283.13% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $197.06 | +97.91% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $176.06 | -3.44% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $220.69 | +31.41% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $16.55 | +341.09% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $4.26 | +745.07% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $4.66 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $221.86 | +59.11% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $95.50 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $88.09 | -4.64% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.99 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $252.03 | -32.55% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $173.77 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $1.36 | +3,282.35% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $568.36 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $7.23
Upside: +1,283.13%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $197.06
Upside: +97.91%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $176.06
Upside: -3.44%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $220.69
Upside: +31.41%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $16.55
Upside: +341.09%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $4.26
Upside: +745.07%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $4.66
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $221.86
Upside: +59.11%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $95.50
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $88.09
Upside: -4.64%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $3.99
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $252.03
Upside: -32.55%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $173.77
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $1.36
Upside: +3,282.35%
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $568.36
Upside: -